Mirae Asset Global ETFs Holdings’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7K Buy
18,355
+402
+2% +$664 ﹤0.01% 3027
2025
Q4
$39.7K Sell
17,953
-373
-2% -$701 ﹤0.01% 2981
2025
Q3
$29.7K Sell
18,326
-3,289
-15% -$6.88K ﹤0.01% 3021
2025
Q2
$56K Sell
21,615
-1,014
-4% -$4K ﹤0.01% 2856
2025
Q1
$152K Buy
22,629
+967
+4% +$6.85K ﹤0.01% 2451
2024
Q4
$147K Buy
21,662
+912
+4% +$6K ﹤0.01% 2543
2024
Q3
$172K Buy
20,750
+1,226
+6% +$8.87K ﹤0.01% 2437
2024
Q2
$124K Buy
+19,524
New +$150K ﹤0.01% 2482

Other funds holding LUNG

Mirae Asset Global ETFs Holdings's LUNG Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Pulmonx (LUNG) stake by 2.2% in Q1 2026, buying an estimated $664 and bringing the position to 18,355 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3027.

Mirae Asset Global ETFs Holdings first reported a position in LUNG in Q2 2024 and has held it in 8 quarters since. The position peaked at $172K in Q3 2024. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 18,355 shares of Pulmonx worth $23.7K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 402 Pulmonx shares in Q1 2026, an estimated $664.
  • Pulmonx made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #3027 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Pulmonx in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Pulmonx position peaked at $172K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.